Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
318.4 USD | +12.34% |
|
0.00% | -11.60% |
Jul. 01 | Bio-Rad Laboratories, Inc.(NYSE:BIO) added to Russell 2500 Value Index | CI |
Jul. 01 | Bio-Rad Laboratories, Inc.(NYSE:BIO) added to Russell 2500 Index | CI |
Chart calendar Bio-Rad Laboratories, Inc.
Upcoming events on Bio-Rad Laboratories, Inc.
Past events on Bio-Rad Laboratories, Inc.
2024-06-06 10:30 am | Jefferies Global Healthcare Conference |
2024-05-14 02:05 pm | RBC Capital Markets Global Healthcare Conference |
2024-05-07 05:00 pm | Q1 2024 Earnings Call |
2024-05-07 04:15 pm | Q1 2024 Earnings Release |
2024-04-23 07:00 pm | Annual General Meeting |
2024-02-29 02:30 pm | Citi Unplugged Medtech and Life Sciences Access Day |
2024-02-15 05:00 pm | Q4 2023 Earnings Call |
2024-02-15 04:15 pm | Q4 2023 Earnings Release |
2024-01-07 | JPMorgan Healthcare Conference |
2023-10-26 05:00 pm | Q3 2023 Earnings Call |
2023-10-26 04:15 pm | Q3 2023 Earnings Release |
2023-09-07 11:00 am | Wells Fargo Healthcare Conference |
2023-08-03 05:00 pm | Q2 2023 Earnings Call |
2023-08-03 04:15 pm | Q2 2023 Earnings Release |
2023-06-08 03:00 pm | Jefferies Global Healthcare Conference |
2023-05-17 03:35 pm | RBC Global Healthcare Conference |
2023-05-04 05:00 pm | Q1 2023 Earnings Call |
2023-05-04 04:15 pm | Q1 2023 Earnings Release |
2023-04-25 07:00 pm | Annual General Meeting |
2023-03-02 11:45 am | Citi Healthcare Services Medtech Tools & HCIT Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 2 312 2 329 -0.73% | 2 546 2 430 4.76% | 2 923 2 893 1.04% | 2 802 2 816 -0.49% | 2 671 2 676 -0.18% | 2 663 |
EBITDA Million USD | Released Forecast Spread | 390 406 -4.12% | 537 522 2.96% | 677 678 -0.04% | 668 635 5.14% | 536 521 2.92% | 472 |
EBIT Million USD | Released Forecast Spread | 279 294 -5.39% | 427 403 5.8% | 571 598 -4.49% | 524 530 -1.09% | 379 383 -1.13% | 343 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 0,00 - | 4 908 3 985 23.15% | 5 438 694 683.59% | 0,00 0,00 - | -850 503 -269.07% | 377 |
Net income Million USD | Released Forecast Spread | 0,00 0,00 - | 3 806 3 087 23.3% | 4 246 541 684.82% | -3 628 -3 508 -3.42% | -637 392 -262.67% | 294 |
EPS USD | Released Forecast Spread | 0,00 0,00 - | 126 102 23.37% | 141 17,9 683.94% | 0,00 0,00 - | -21,8 13,5 -262.11% | 10,3 |
Announcement Date | 13/02/20 | 11/02/21 | 10/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 700 677 3.48% | 691 674 2.6% | 681 683 -0.28% | 730 741 -1.45% | 677 689 -1.8% | 681 696 -2.12% | 632 692 -8.61% | 681 687 -0.79% | 611 620 -1.5% | 646 | 655 | 731 | 647 | 673 |
EBITDA Million USD | Released Forecast Spread | 179 138 30.25% | 156 135 16.12% | 132 140 -5.26% | 156 167 -6.51% | 149 151 -1.79% | 138 134 2.51% | 113 143 -21.03% | 137 136 0.61% | 109 91,3 18.86% | 95,8 | 115 | 156 | 107 | 115 |
EBIT Million USD | Released Forecast Spread | 154 109 41.6% | 130 106 23.09% | 106 111 -4.46% | 127 140 -9.16% | 84,2 122 -31.13% | 108 106 2.07% | 81,6 112 -27.14% | 105 107 -1.39% | 59,0 61,8 -4.48% | 67,2 | 84,4 | 123 | 75,6 | 85,2 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 500 108 -1491.07% | |||||||||||||
Net income Million USD | Released Forecast Spread | 828 953 -13.17% | -1 162 83,6 -1490.39% | 350 | |||||||||||
EPS USD | Released Forecast Spread | -5,52 2,63 -309.89% | -39,6 2,81 -1508.9% | ||||||||||||
Announcement Date | 28/04/22 | 28/07/22 | 27/10/22 | 16/02/23 | 04/05/23 | 03/08/23 | 26/10/23 | 15/02/24 | 07/05/24 | - | - | - | - | - |
2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
2024-07-18 07:30 am | ABBOTT LABORATORIES: Q2 2024 Earnings Release |
2024-07-19 01:00 am | SARTORIUS STEDIM BIOTECH: Q2 2024 Earnings Release |
2024-07-24 04:00 pm | ALIGN TECHNOLOGY, INC.: Q2 2024 Earnings Release |
2024-07-24 | TELEFLEX INCORPORATED: Q2 2024 Earnings Release (Projected) |
2024-07-24 | WEST PHARMACEUTICAL SERVICES, INC.: Q2 2024 Earnings Release |
2024-07-24 | BIO-RAD LABORATORIES, INC.: Q2 2024 Earnings Release (Projected) |
2024-07-24 | BAXTER INTERNATIONAL INC.: Q2 2024 Earnings Release (Projected) |
2024-07-25 04:03 pm | DEXCOM, INC.: Q2 2024 Earnings Release |
2024-07-25 | AVANTOR, INC.: Q2 2024 Earnings Release |
Past sector events for Bio-Rad Laboratories, Inc.
2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
2024-07-12 01:00 am | ARJO AB: Q2 2024 Earnings Release |
2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
2024-07-04 | MANI, INC.: Q3 2024 Earnings Release |
2024-06-27 01:00 am | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
2024-06-18 07:00 am | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release |
2024-06-07 03:14 am | TAIDOC TECHNOLOGY CORPORATION: May 2024 Sales and Revenue Release |
2024-06-05 06:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
2024-05-27 04:30 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BIO Stock
- BIO.B Stock
- Calendar Bio-Rad Laboratories, Inc.